About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Global Virus Safety Testing Services Market Size, Top Share, Report to 2032
Virus Safety Testing Services Market

Virus Safety Testing Services Market Size, Share & Trends Analysis Report By Test Type (Adventitious Virus Tests, Antibody Production Tests, Retrovirus Tests, Specific Virus Tests), By Applications (Vaccines, Plasma Proteins, Antibody, Gene Therapy, Regenerative Medicine) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI55541DR
Last Updated : Oct 24, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Virus Safety Testing Services Market Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Adventitious Virus Tests
        1. By Value
      3. Antibody Production Tests
        1. By Value
      4. Retrovirus Tests
        1. By Value
      5. Specific Virus Tests
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Vaccines
        1. By Value
      3. Plasma Proteins
        1. By Value
      4. Antibody
        1. By Value
      5. Gene Therapy
        1. By Value
      6. Regenerative Medicine
        1. By Value
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Adventitious Virus Tests
        1. By Value
      3. Antibody Production Tests
        1. By Value
      4. Retrovirus Tests
        1. By Value
      5. Specific Virus Tests
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Vaccines
        1. By Value
      3. Plasma Proteins
        1. By Value
      4. Antibody
        1. By Value
      5. Gene Therapy
        1. By Value
      6. Regenerative Medicine
        1. By Value
    4. U.S.
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Adventitious Virus Tests
          1. By Value
        3. Antibody Production Tests
          1. By Value
        4. Retrovirus Tests
          1. By Value
        5. Specific Virus Tests
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Vaccines
          1. By Value
        3. Plasma Proteins
          1. By Value
        4. Antibody
          1. By Value
        5. Gene Therapy
          1. By Value
        6. Regenerative Medicine
          1. By Value
    5. Canada
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Adventitious Virus Tests
        1. By Value
      3. Antibody Production Tests
        1. By Value
      4. Retrovirus Tests
        1. By Value
      5. Specific Virus Tests
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Vaccines
        1. By Value
      3. Plasma Proteins
        1. By Value
      4. Antibody
        1. By Value
      5. Gene Therapy
        1. By Value
      6. Regenerative Medicine
        1. By Value
    4. U.K.
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Adventitious Virus Tests
          1. By Value
        3. Antibody Production Tests
          1. By Value
        4. Retrovirus Tests
          1. By Value
        5. Specific Virus Tests
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Vaccines
          1. By Value
        3. Plasma Proteins
          1. By Value
        4. Antibody
          1. By Value
        5. Gene Therapy
          1. By Value
        6. Regenerative Medicine
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Adventitious Virus Tests
        1. By Value
      3. Antibody Production Tests
        1. By Value
      4. Retrovirus Tests
        1. By Value
      5. Specific Virus Tests
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Vaccines
        1. By Value
      3. Plasma Proteins
        1. By Value
      4. Antibody
        1. By Value
      5. Gene Therapy
        1. By Value
      6. Regenerative Medicine
        1. By Value
    4. China
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Adventitious Virus Tests
          1. By Value
        3. Antibody Production Tests
          1. By Value
        4. Retrovirus Tests
          1. By Value
        5. Specific Virus Tests
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Vaccines
          1. By Value
        3. Plasma Proteins
          1. By Value
        4. Antibody
          1. By Value
        5. Gene Therapy
          1. By Value
        6. Regenerative Medicine
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Singapore
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Adventitious Virus Tests
        1. By Value
      3. Antibody Production Tests
        1. By Value
      4. Retrovirus Tests
        1. By Value
      5. Specific Virus Tests
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Vaccines
        1. By Value
      3. Plasma Proteins
        1. By Value
      4. Antibody
        1. By Value
      5. Gene Therapy
        1. By Value
      6. Regenerative Medicine
        1. By Value
    4. UAE
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Adventitious Virus Tests
          1. By Value
        3. Antibody Production Tests
          1. By Value
        4. Retrovirus Tests
          1. By Value
        5. Specific Virus Tests
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Vaccines
          1. By Value
        3. Plasma Proteins
          1. By Value
        4. Antibody
          1. By Value
        5. Gene Therapy
          1. By Value
        6. Regenerative Medicine
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Adventitious Virus Tests
        1. By Value
      3. Antibody Production Tests
        1. By Value
      4. Retrovirus Tests
        1. By Value
      5. Specific Virus Tests
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Vaccines
        1. By Value
      3. Plasma Proteins
        1. By Value
      4. Antibody
        1. By Value
      5. Gene Therapy
        1. By Value
      6. Regenerative Medicine
        1. By Value
    4. Brazil
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Adventitious Virus Tests
          1. By Value
        3. Antibody Production Tests
          1. By Value
        4. Retrovirus Tests
          1. By Value
        5. Specific Virus Tests
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Vaccines
          1. By Value
        3. Plasma Proteins
          1. By Value
        4. Antibody
          1. By Value
        5. Gene Therapy
          1. By Value
        6. Regenerative Medicine
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Virus Safety Testing Services Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Charles River Laboratories, Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Eurofins Scientific
    3. SGS SA
    4. Merck KGaA
    5. Sartorius Stedim BioOutsource Limited
    6. WuXi Biologics
    7. ViSpot Co., Ltd.
    8. Syngene International Ltd.
    9. Laboratory Corporation of America Holdings
    10. Creative Biogene
    11. Asahi Kasei Corporation
    12. Texcell
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The cannabis testing services market size was valued at USD 1,120 million in 2019 and is expected to grow with a CAGR of 15.2%. Cannabis testing services involve evaluating the active ingredients and essential chemical compounds in the specified can
Buy Now
Global Report
The global drug of abuse testing services market size was valued at USD 3.85 billion in 2022. It is estimated to reach USD 7.25 billion by 2031, growing at a CAGR of 6.4% during the forecast period (2023–2031). The utilization of certain chemi
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright . All rights Reserved.